vs

Side-by-side financial comparison of BayFirst Financial Corp. (BAFN) and EXAGEN INC. (XGN). Click either name above to swap in a different company.

EXAGEN INC. is the larger business by last-quarter revenue ($16.6M vs $10.3M, roughly 1.6× BayFirst Financial Corp.). EXAGEN INC. runs the higher net margin — -28.1% vs -55.0%, a 26.9% gap on every dollar of revenue. Over the past eight quarters, EXAGEN INC.'s revenue compounded faster (7.4% CAGR vs -29.6%).

The PNC Financial Services Group, Inc. is an American bank holding company and financial services corporation based in Pittsburgh, Pennsylvania. Its banking subsidiary, PNC Bank, operates in 27 states and the District of Columbia, with 2,629 branches and 9,523 ATMs. PNC Bank is one of the largest banks in the US by assets and by number of branches, deposits, and ATMs.

Exagen Inc. is a clinical diagnostics company specializing in developing, manufacturing, and commercializing proprietary testing solutions for autoimmune, rheumatic, and related chronic diseases. It mainly operates in the U.S. market, serving healthcare providers and patients to support accurate disease diagnosis and treatment monitoring.

BAFN vs XGN — Head-to-Head

Bigger by revenue
XGN
XGN
1.6× larger
XGN
$16.6M
$10.3M
BAFN
Higher net margin
XGN
XGN
26.9% more per $
XGN
-28.1%
-55.0%
BAFN
Faster 2-yr revenue CAGR
XGN
XGN
Annualised
XGN
7.4%
-29.6%
BAFN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BAFN
BAFN
XGN
XGN
Revenue
$10.3M
$16.6M
Net Profit
$-5.7M
$-4.7M
Gross Margin
55.4%
Operating Margin
-29.9%
Net Margin
-55.0%
-28.1%
Revenue YoY
21.8%
Net Profit YoY
-130.6%
-24.2%
EPS (diluted)
$-1.48
$-0.21

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BAFN
BAFN
XGN
XGN
Q1 26
$10.3M
Q4 25
$11.2M
$16.6M
Q3 25
$10.2M
$17.2M
Q2 25
$23.1M
$17.2M
Q1 25
$19.8M
$15.5M
Q4 24
$32.9M
$13.7M
Q3 24
$21.7M
$12.5M
Q2 24
$20.8M
$15.1M
Net Profit
BAFN
BAFN
XGN
XGN
Q1 26
$-5.7M
Q4 25
$-2.5M
$-4.7M
Q3 25
$-18.9M
$-7.1M
Q2 25
$-1.2M
$-4.4M
Q1 25
$-335.0K
$-3.8M
Q4 24
$9.8M
$-3.8M
Q3 24
$1.1M
$-5.0M
Q2 24
$866.0K
$-3.0M
Gross Margin
BAFN
BAFN
XGN
XGN
Q1 26
Q4 25
55.4%
Q3 25
58.4%
Q2 25
60.4%
Q1 25
58.9%
Q4 24
62.1%
Q3 24
55.8%
Q2 24
60.1%
Operating Margin
BAFN
BAFN
XGN
XGN
Q1 26
Q4 25
-25.3%
-29.9%
Q3 25
-253.0%
-18.0%
Q2 25
-7.1%
-15.3%
Q1 25
-2.3%
-21.7%
Q4 24
-24.8%
Q3 24
7.1%
-37.3%
Q2 24
5.9%
-17.2%
Net Margin
BAFN
BAFN
XGN
XGN
Q1 26
-55.0%
Q4 25
-22.1%
-28.1%
Q3 25
-184.7%
-41.1%
Q2 25
-5.3%
-25.8%
Q1 25
-1.7%
-24.2%
Q4 24
91.8%
-27.5%
Q3 24
5.2%
-40.2%
Q2 24
4.2%
-19.7%
EPS (diluted)
BAFN
BAFN
XGN
XGN
Q1 26
$-1.48
Q4 25
$-0.71
$-0.21
Q3 25
$-4.66
$-0.31
Q2 25
$-0.39
$-0.21
Q1 25
$-0.17
$-0.20
Q4 24
$2.21
$-0.20
Q3 24
$0.18
$-0.28
Q2 24
$0.12
$-0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BAFN
BAFN
XGN
XGN
Cash + ST InvestmentsLiquidity on hand
$134.5M
$32.2M
Total DebtLower is stronger
$22.9M
Stockholders' EquityBook value
$81.9M
$17.4M
Total Assets
$1.2B
$58.0M
Debt / EquityLower = less leverage
1.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BAFN
BAFN
XGN
XGN
Q1 26
$134.5M
Q4 25
$207.0M
$32.2M
Q3 25
$118.5M
$35.7M
Q2 25
$77.3M
$30.0M
Q1 25
$63.2M
$11.2M
Q4 24
$77.8M
$22.0M
Q3 24
$64.4M
$22.0M
Q2 24
$60.8M
$24.5M
Total Debt
BAFN
BAFN
XGN
XGN
Q1 26
Q4 25
$22.9M
Q3 25
$22.9M
Q2 25
$23.0M
Q1 25
$20.9M
Q4 24
$20.2M
Q3 24
$20.3M
Q2 24
$20.3M
Stockholders' Equity
BAFN
BAFN
XGN
XGN
Q1 26
$81.9M
Q4 25
$87.6M
$17.4M
Q3 25
$89.7M
$18.1M
Q2 25
$108.2M
$21.0M
Q1 25
$110.1M
$6.4M
Q4 24
$110.9M
$9.5M
Q3 24
$102.3M
$12.9M
Q2 24
$101.0M
$17.6M
Total Assets
BAFN
BAFN
XGN
XGN
Q1 26
$1.2B
Q4 25
$1.3B
$58.0M
Q3 25
$1.3B
$62.8M
Q2 25
$1.3B
$58.8M
Q1 25
$1.3B
$40.3M
Q4 24
$1.3B
$44.7M
Q3 24
$1.2B
$43.6M
Q2 24
$1.2B
$49.3M
Debt / Equity
BAFN
BAFN
XGN
XGN
Q1 26
Q4 25
1.31×
Q3 25
1.26×
Q2 25
1.09×
Q1 25
3.27×
Q4 24
2.12×
Q3 24
1.57×
Q2 24
1.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BAFN
BAFN
XGN
XGN
Operating Cash FlowLast quarter
$-3.0M
Free Cash FlowOCF − Capex
$-3.1M
FCF MarginFCF / Revenue
-18.4%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-14.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BAFN
BAFN
XGN
XGN
Q1 26
Q4 25
$285.3M
$-3.0M
Q3 25
$47.3M
$2.9M
Q2 25
$63.3M
$-2.9M
Q1 25
$74.2M
$-10.7M
Q4 24
$390.5M
$363.0K
Q3 24
$90.8M
$-2.2M
Q2 24
$78.8M
$-2.4M
Free Cash Flow
BAFN
BAFN
XGN
XGN
Q1 26
Q4 25
$285.0M
$-3.1M
Q3 25
$47.3M
$2.7M
Q2 25
$63.1M
$-3.1M
Q1 25
$74.1M
$-10.8M
Q4 24
$388.8M
$217.0K
Q3 24
$90.5M
$-2.3M
Q2 24
$78.4M
$-2.6M
FCF Margin
BAFN
BAFN
XGN
XGN
Q1 26
Q4 25
2554.2%
-18.4%
Q3 25
462.2%
15.5%
Q2 25
272.7%
-18.0%
Q1 25
375.1%
-69.6%
Q4 24
1180.9%
1.6%
Q3 24
416.5%
-18.6%
Q2 24
376.1%
-17.0%
Capex Intensity
BAFN
BAFN
XGN
XGN
Q1 26
Q4 25
2.7%
0.3%
Q3 25
0.1%
1.6%
Q2 25
0.8%
1.2%
Q1 25
0.4%
0.7%
Q4 24
5.1%
1.1%
Q3 24
1.5%
1.2%
Q2 24
1.9%
0.9%
Cash Conversion
BAFN
BAFN
XGN
XGN
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
39.95×
Q3 24
79.85×
Q2 24
90.94×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BAFN
BAFN

Net Interest Income$9.4M91%
Noninterest Income$884.0K9%

XGN
XGN

Commercial$9.3M56%
Government1$4.3M26%
Client Direct Bill$2.9M18%

Related Comparisons